OPEN ACCESS JOURNALS
           
home about us journals search

Research in Pharmaceutical Biotechnology

     
   RPB Home
   About RPB
   Submit Manuscripts
   Instructions for Authors
   Editors
   Call For Paper
   Archive
   Editorial Team
   Conferences
   Associations

  Res. Pharm. Biotech.

 

  Vol. 2 No. 1

  Viewing options:


  •Reprint (PDF) (100k)

  Search Pubmed for articles by:

 Lu Z

  Other links:
  PubMed Citation
  Related articles in PubMed

Other Journals
African Journal of Agricultural Research
African Journal  of Environmental Science & Technology
Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research
African Journal of Pure & Applied Chemistry
African Journal of Food Science
Journal of Cell & Animal Biology
African Journal of Pharmacy & Pharmacology

African Journal of Biotechnology
Journal of Medicinal Plant Research
International Journal of Physical Sciences
Scientific Research and Essays
 

Research in Pharmaceutical Biotechnology Vol. 2 (1), pp.007013, February 2010© 2010 Academic Journals  

 

Full Length Research Paper

 

Potential therapeutic interventions on toll like receptors for clinical applications

 

Zhengwu Lu

 

1006 S De Anza Blvd#K104, San Jose, CA 95129, USA.

E-mail: Zhengwu.Lu@ieee.org.

 

Accepted 30 October, 2009

 

   Abstract

 

Toll like receptors (TLRs) function as pattern-recognition receptors (PRRs) and play key roles in the recognition of microbial components or endogenous ligands induced during inflammatory response. Studies on TLR-deficient mice have indicated TLRs' involvement in multiple pathologic conditions, and targeting of either the TLRs themselves or the signals they generate is proving to be of great interest to researchers as evidenced by increased research findings among immunologists, pharmacologist, and pharmaceutical scientists on TLRs. As animal models, cellular and molecular mechanisms on TLR mediated disease pathogenesis are made available, drug intervention strategies and early stage clinical studies can be planned and initiated to seek clinical proof for justifying TLRs and their associated signaling pathway/molecules as therapeutic targets. Moreover, a key functional output from TLRs is the generation of inflammatory cytokines such as tumor necrosis factor (TNF) and IL-6, which are excellent targets for inflammatory diseases such as rheumatoid arthritis.

 

Key words: TLR, PRR, NF-κB, agonist, antagonist, drug discovery.

___________________________________________________________________________________________________________

Advertise on RPB | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2010